Recent Company News

• 01:14 PM ET Jun 11, 2025
  

  Grifols successfully completes Biotest delisting (€10.47, 0.00)

• 10:53 AM ET Jun 03, 2025
  

  Biotest AG announces delisting of Biotest shares from the Frankfurt Stock Exchange with effect from 6-Jun-25 (€29.80, -0.20)

• 11:04 AM ET May 28, 2025
  

  Biotest today decided to replace its CEO, Mr Janssen, with immediate effect (€42.60, -0.20)

• 11:42 AM ET May 12, 2025
  

  Biotest reports Q1 earnings after taxes (€21.4M) vs year-ago €29.5M (€30.00, 0.00)

• 11:07 AM ET May 12, 2025
  

  StreetAccount M&A Summary: Week of 5-May

• 07:46 AM ET May 06, 2025
  

  Germany's BaFin approves Grifols offer document connected with the delisting offer for Biotest; acceptance period begins today (€30.00, -0.20)

• 03:05 PM ET Apr 17, 2025
  

  StreetAccount Activist Summary: Week of 14-Apr

• 02:34 AM ET Apr 15, 2025
  

  Biotest holder Westbourne River Partners expresses concerns over Grifols delisting offer in letter to Biotest's board (€30.00, 0.00)

• 12:33 PM ET Apr 07, 2025
  

  StreetAccount M&A Summary: Week of 31-Mar

• 02:50 AM ET Mar 31, 2025
  

  Biotest concludes delisting agreement with Grifols; Grifols Biotest Holdings GmbH to make unconditional public delisting acquisition offer for Biotest AG for €43.00/share in cash (€29.30, 0.00)